Development and application of PROVAX™ adjuvant formulation for subunit cancer vaccines
-
Published:1998-07-06
Issue:3
Volume:32
Page:187-197
-
ISSN:0169-409X
-
Container-title:Advanced Drug Delivery Reviews
-
language:en
-
Short-container-title:Advanced Drug Delivery Reviews
Subject
Pharmaceutical Science
Reference55 articles.
1. J.L. Bussiere, G.C. McCormick and J.D. Green, Pre-clinical Safety Assessment Considerations in Vaccine Development, in: Vaccine Design: The Subunit and Adjuvant Approach, Plenum Press, New York, 1995, pp. 61–79.
2. Vaccine R & D success rates and development times;Struck;Nature Biotechnol.,1996
3. M.J. Newman, M.F. Powell, Immunological and Formulation Design Considerations for Sub-unit Vaccines, in: Vaccine Design: The Sub-unit and Adjuvant Approach. Plenum Press, New York, (1995) pp. 61–79.
4. Cancer vaccines: a road map for the next decade;Pardoll;Curr. Opin. Immunol.,1996
5. Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapy;Baxevanis;Crit. Rev. Hematol.,1994
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献